
    
      At present, there is no validated biological diagnostic marker for amyotrophic lateral
      sclerosis (ALS). The main objective of the study is to isolate a set of genes that are
      specifically dysregulated in muscle from ALS patients.

      Gene profiling in muscle will be compared between ALS patients and patients with other motor
      neuron diseases (SMA and SBMA)
    
  